PACS Group, Inc. Common Stock (PACS)
Healthcare › Services-Skilled Nursing Care Facilities
Price History
Feb 9, 2026 — Aug 13, 2026Investment Snapshot
- Trading 160% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 23.5% — good return on equity
- Revenue growing at 29% annually
PACS Group, Inc. Common Stock (PACS) is a Healthcare company operating in Services-Skilled Nursing Care Facilities, listed on the NYSE , with a market capitalisation of $6.6 billion . Key value metrics: P/E ratio 25.5, P/B ratio 5.97, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 3 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
PACS Group, Inc. Common Stock — Fundamental Analysis Summary
PACS Group, Inc. Common Stock (PACS) is currently trading 160% above its Graham Number of $16.11, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 25.5x.
On financial health, PACS shows a moderate Piotroski F-Score of 6/9, and strong return on equity of 23.5% (sector average: -20.1%), and minimal leverage with a debt-to-equity ratio of 0.22.
StockPik's composite Value Score for PACS is 72/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
PACS shows revenue growing at 29% year-over-year, with earnings growing at 244%.
PACS pays a modest dividend yield of 0.5%.